{
  "book_page": 149,
  "pdf_page": 75,
  "content": {
    "main_concept": "Methylergonovine Maleate (Methergine) - Contraindications and Safety",
    "key_points": "**CONCEPT: Methylergonovine maleate (Methergine) initially causes hypertension.**\\n\\n**Medication Overview:**\\n\\n- **Classification**: Methylergonovine maleate (Methergine) is an oxytocic\\n- **Indication**: Used as a treatment for postpartum atony and hemorrhage\\n- **Therapeutic effect**: Manifested by a firmly contracted uterus\\n\\n**Safety Considerations:**\\n\\n- **Monitor the BP; it causes hypertension**\\n- **Report difficulty of breathing**\\n- **Contraindication**: Should be withheld in clients with hypertension",
    "questions": [
      {
        "id": 1,
        "type": "multiple_choice",
        "question_text": "Which of the following findings reflects a need to withhold methylergonovine maleate (Methergine)?",
        "options": [
          "1. Respiratory rate of 14 per minute",
          "2. Blood pressure of 160/110 mm Hg",
          "3. Positive Brudzinski's sign",
          "4. Negative Babinski reflex"
        ],
        "correct_answer": "2",
        "rationale": "**RATIONALE**\\n\\nMethylergonovine maleate (Methergine) should be withheld in a client with high blood pressure since it causes hypertension."
      }
    ]
  },
  "images": [],
  "extraction_metadata": {
    "timestamp": "2025-09-18T03:53:54Z",
    "extraction_confidence": "high",
    "human_validated": false,
    "notes": "Complete concept from right side of PDF page 75, includes question about contraindications, comprehensive safety information for oxytocic medication in postpartum care",
    "category": "Pharmacological and Parenteral Therapies",
    "reference": "Karch, Amy, Lippincott's Nursing Drug Guide Philadelphia, Lippincott Williams and Wilkins"
  }
}